Caregen is a publicly listed leader in peptide biotechnology (KOSDAQ: 214370), headquartered in South Korea. Since 2001, the company has developed over 1,800 proprietary peptides and secured more than 860 global patents across pharmaceuticals, nutraceuticals, medical aesthetics, and cosmeceuticals.

Backed by over 25 years of research and global manufacturing capabilities, Caregen delivers science-driven peptide solutions for wellness, aging, metabolic health, and aesthetic applications.